Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03080168 · ClinicalTrials.gov registry record
The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 220
- Enrollment target
NCT03080168: Completed study, sponsored by VA Office of Research and Development.
NCT03080168 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03080168 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
This is a research project looking at whether measuring movements or responses to certain questions can help predict suicidal thoughts or actions. This project has two parts: The first part will occur while the participant is receiving hospitalized at the Bedford VA Hospital. It involves wearing a watch-like device on his/her wrist and answering questions or doing tasks to measure mood and other mental health symptoms, and suicidal thoughts. In the second phase, the investigators will call the participant around 12 months after s/he has left the hospital. The investigators will discuss how s/he is doing and if s/he has had suicidal thoughts or made suicidal acts.
Primary Outcome
The investigators will call some participants who are not undergoing alcohol detoxification and administer the Columbia-Suicide Severity Rating Scale to determine occurrence of all suicidal behavior (actual, interrupted, aborted, and preparatory), ask them to also self-report rehospitalization with suicidal ideation (SI), and use VA chart data as another source of information about suicidal behavior and rehospitalization. For those patients who we reach by phone we will use both their self-repo
Interventions
- DEVICE Actigraph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2017-02-21 |
| Est. Completion | 2021-04-01 |
What the finished NCT03080168 record still lists
NCT03080168 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Actigraph is the first listed.
NCT03080168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03080168 about?
NCT03080168 is a clinical study titled "The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety". This is a research project looking at whether measuring movements or responses to certain questions can help predict suicidal thoughts or actions. This project has two parts: The first part will occur while the participant is receiving hospitalized at the Bedford VA Hospital. It involves wearing a ...
What is the current status of trial NCT03080168?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2017-02-21. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT03080168?
The interventions under investigation include: Actigraph (DEVICE).
Who is sponsoring clinical trial NCT03080168?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI